ESC 365 - Pharmacotherapy for atrial fibrillation in patients with chronic kidney disease: insights from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT AF)

ESC Premium Access

Pharmacotherapy for atrial fibrillation in patients with chronic kidney disease: insights from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT AF)

Session: Poster session 4 - Miscellaneous in arrhythmia

Topic: Antiarrhythmic drugs

Speaker: Professor J. Piccini (Durham, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Jonathan Piccini

Duke University Medical Center, Durham (United States of America)

5 presentations

1 follower

28 more presentations in this session

A novel CACNA1C mutation identified in a patient with atypical Timothy syndrome exerts both loss- and gain-of-function effects on Cav1.2.

Speaker: Doctor J. Ozawa (Niigata, JP)

Genetic testing in a consecutive series of young athletes with suspected cathecolaminargic polymorphic ventricular tachycardia

Speaker: Associate Professor N. Marziliano (Milan, IT)

The burden of complex arrhythmic genotypes in a consecutive series of Sardinian population of patients with primary arrhythmic disorders

Speaker: Associate Professor N. Marziliano (Milan, IT)

Discrepancy of QTc duration and LQTS risk score for the diagnosis of type 3 LQTS

Speaker: Doctor A. Hermida (Paris, FR)

Complex inherited cardiac diseases inheritance in a family harbouring compound SCN5A and MYBPC3 mutations.

Speaker: Doctor R. Mango (Rome, IT)

Access the full session

Poster session 4 - Miscellaneous in arrhythmia

Speakers: Professor J. Piccini, Doctor J. Ozawa, Associate Professor N. Marziliano, Associate Professor N. Marziliano, Doctor A. Hermida...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources